Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2021

May 19, 2021

33298_dirs_2021-05-19_68b0fbe0-03c1-4803-b40c-e33820ca5d1e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2021-05-19

Reporting Person: Yecies Eric Harold (CCO and General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-19 Common Stock P 11100 $9.24 Acquired 16100 Direct

Footnotes

F1: The price reported represents the weighted average price of shares purchased. The shares were purchased at varying prices in the range of $9.18 - $9.30. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each price.